การฉายรังสีแบบปรับความเข้ม ในมะเร็งบริเวณศีรษะและลำคอ (IMRT of Head and Neck Cancer)

Lertbutsayanukul C, Rojpornpradit P. Intensity Modulated Radiation Therapy. Journal of Thai Society of Therapeutic Radiology and Oncology 2005;11:13-29

Hudgins PA, Gussack GS. MR imaging in the management of extracranial malignant tumors of the head and neck. AJR Am J Roentgenol. 1992;159:161-9.

Som PM. The present controversy over the imaging method of choice for evaluating the soft tissues of the neck. AJNR Am J Neuroradiol. 1997;18:1869-72.

Glazer HS, Niemeyer JH, Balfe DM, Hayden RE, Emami B, Devineni VR, et al. Neck neoplasms: MR imaging. Part II. Posttreatment evaluation. Radiology. 1986;160:349-54.

Adams S, Baum RP, Stuckensen T, Bitter K, H?r G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998;25:1255-60.

Kau RJ, Alexiou C, Laubenbacher C, Werner M, Schwaiger M, Arnold W. Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting. Arch
Otolaryngol Head Neck Surg. 1999;125:1322-8.

Nowak B, Di Martino E, J?nicke S, Cremerius U, Adam G, Zimny M, et al. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI. Nuklearmedizin. 1999;38:312-8.

Greven KM, Williams DW 3rd, McGuirt WF Sr, Harkness BA, D'Agostino RB Jr, Keyes JW Jr, et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck. 2001;23:942-6.

Lowe VJ, Boyd JH, Dunphy FR, Kim H, Dunleavy T, Collins BT, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol. 2000;18:651-8.

Barrington SF, Maisey MN.Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med. 1996;37:1127-9.

ICRU Report 50 : Prescribing, recording and reporting photon beam therapy. Bethesda, MD: International Commission on Radiation Units and Measurement, 1993: 1-72

ICRU Report 62: Prescribing, recarding and reporting photon beam therapy (supplement to ICRU Report 50). Bethesda, MD: International Commission on Radiation Units and Measurement, 1999: 1-52

Eisbruch A, Foote RL, O'Sullivan B, Beitler JJ, Vikram B. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Radiat Oncol. 2002;12:238-49.

Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg.
1991;117:601-5.

Robbins KT. Integrating radiological criteria into the classification of cervical lymph node disease. Arch Otolaryngol Head Neck Surg. 1999 ;125:385-7

Som PM, Curtin HD, Mancuso AA.An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg. 1999; 125:388-96.

Chao KS, Wippold FJ, Ozyigit G, Tran BN, Dempsey JF.Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys.
2002;53:1174-84.

Nowak PJ, Wijers OB, Lagerwaard FJ, Levendag PC. A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys. 1999;45:33-9.

Wijers OB, Levendag PC, Tan T, van Dieren EB, van S?rnsen de Koste J, van der Est H, et al. A simplified CT-based definition of the lymph node levels in the node negative neck. Radiother Oncol. 1999;52:35-42.

Gr?goire V, Coche E, Cosnard G, Hamoir M, Reychler H. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience.
Radiother Oncol. 2000;56:135-50.

Gr?goire V, Eisbruch A, Hamoir M, Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol. 2006;79:15-20.

Martinez-Monge R, Fernandes PS, Gupta N, Gahbauer R. Cross-sectional nodal atlas: a tool for the definition of clinical target volumes in three-dimensional radiation therapy planning. Radiology. 1999;211:815-28.

Poon I, Fischbein N, Lee N, Akazawa P, Xia P, Quivey J, et al. A population-based atlas and clinical target volume for the head-and-neck lymph nodes. Int J Radiat Oncol Biol Phys. 2004;59:1301-11.

van den Brekel MW, Stel HV, Castelijns JA, Nauta JJ, van der Waal I, Valk J, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology. 1990 ;177:379-84.

Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990;66:109-13.

Candela FC, Kothari K, Shah JP. Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck. 1990 ;12:197-203.

Candela FC, Shah J, Jaques DP, Shah JP. Patterns of cervical node metastases from squamous carcinoma of the larynx. Arch Otolaryngol Head Neck Surg. 1990;116:432-5.

Harrison DF. The pathology and management of subglottic cancer. Ann Otol Rhinol Laryngol. 1971;80:6-12.

Marks JE, Devineni VR, Harvey J, Sessions DG. The risk of contralateral lymphatic metastases for cancers of the larynx and pharynx. Am J Otolaryngol. 1992;13:34-9.

Koo BS, Lim YC, Lee JS, Kim YH, Kim SH, Choi EC. Management of contralateral N0 neck in pyriform sinus carcinoma. Laryngoscope. 2006 ;116:1268-72.

Hasegawa Y, Matsuura H. Retropharyngeal node dissection in cancer of the oropharynx and hypopharynx. Head Neck. 1994;16:173-80.

Okumura K, Fujimoto Y, Hasegawa Y, Matsuura H, Nakayama B, Komura T, et al. Retropharyngeal node metastasis in cancer of the oropharynx and hypopharynx: analysis of retropharyngeal node dissection regarding preoperative radiographic
diagnosis. Nippon Jibiinkoka Gakkai Kaiho. 1998;101:573-7.

McLaughlin MP, Mendenhall WM, Mancuso AA, Parsons JT, McCarty PJ, Cassisi NJ, et al. Retropharyngeal adenopathy as a predictor of outcome in squamous cell carcinoma of the head and neck. Head Neck. 1995;17:190-8.

Chua DT, Sham JS, Kwong DL, Au GK, Choy DT. Retropharyngeal lymphadenopathy in patients with nasopharyngeal carcinoma: a computed tomography-based study. Cancer. 1997;79:869-77.

Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004; 59: 28-42.

Naiyanet N, Oonsiri S, Lertbutsayanukul C, Suriyapee S. Measurements of patient's setup variation in intensitymodulated radiation therapy of head and neck cancer using electronic portal imaging device. Biomed Imaging Interv J 2007; 3(1):e30

Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16.

Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys. 2000;46:619-30.

Eisbruch A, Chao KS, Garden A. Phase I/II study of conformal and intensity modulated irradiation for oropharyngeal cancer, RTOG H-0022 [Web Page]. 2001; Available at http://rtog.org/members/protocols/h0022/h0022.pdf.

Wu Q, Mohan R, Morris M, Lauve A, Schmidt-Ullrich R. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and neck squamous cell carcinomas. I: dosimetric results. Int J Radiat Oncol Biol Phys 2003; 56: 573-585

Butler EB, The BS, Grant WH, Uhl BM, Kuppersmith RB, Chiu JK, et al. SMART (Simutaneous modulated accelerated radiation therapy) Boost: a new accelerated fractionation schedule for the treatment of head and ncek cancer with intensity modulated radiology. Int J Radiat Oncol Biol Phys 1999; 45:21-32.

Fogliata A, Bolsi A, Cozzi L, Bernier J. Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients. Radiother Oncol. 2003 ;69:267-75.

Ang KK, Garden AS. Modes of therapy. In Radiotherapy for head and neck cancers: indication and techniques edited by Ang KK, Garden AS. Lippincott Williams & Wilkins 2nd ed 2002: 12-14

Lee N, Garden A, Kramer A, Xia P. A Phase II study of intensity modulated radiation therapy (IMRT) +/- chemotherapy for nasopharyngeal Cancer. [Web Page]. Available at htttp://www.rtog.org/members/protocols/0225/0225.pdf

Cooper JS, Fu K, Marks J, Silverman S. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys. 1995;31:1141-64.

Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577-87.

Blanco AI, Chao KS, El Naqa I, Franklin GE, Zakarian K, Vicic M, et al. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:1055-69.

Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat
Oncol Biol Phys. 2001;49:907-16.

Kwong DL, Pow EH, Sham JS, McMillan AS, Leung LH, Leung WK, et al. Intensitymodulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer.
2004;101:1584-93.

Chong LM, Hunt MA. IMRT for head and neck cancer In: Members of the staff of Memorial Sloan-Kettering Cancer Center, editors. A practical guide to intensitymodulated radiation therapy. Wisconsin: Medical Physica Publishing; 2003: 191-218

Choi S, Wolden S, Pfister D, Budnick AS, Leregrun S, Jackson A, et al. Ototoxicity following combined modality therapy for nasopharyngeal carcinoma. Proceedings of the 42nd annual ASTRO meeting, Boston, MA; 2000 Oct 22-26. Int J Radiat Oncol
Biol Phys 2000: 48: 261

Anteunis LJ, Wanders SL, Hendriks JJ, Langendijk JA, Manni JJ, de Jong JM. A prospective longitudinal study on radiation-induced hearing loss. Am J Surg. 1994;168:408-11.

Grau C, M?ller K, Overgaard M, Overgaard J, Elbr?nd O. Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1991;21:723-8.

Kwong DL, Wei WI, Sham JS, Ho WK, Yuen PW, Chua DT, et al. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys. 1996
1;36:281-9.

Raaijmakers E, Engelen AM. Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature. Radiother Oncol. 2002;65:1-7.

Ho WK, Wei WI, Kwong DL, Sham JS, Tai PT, Yuen AP, et al. Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study. Head Neck. 1999;21:547-53.

Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys. 2007;67:469-79.

Low WK, Toh ST, Wee J, Fook-Chong SM, Wang DY. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study. J Clin Oncol. 2006;24:1904-9.

Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, et al. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer. 2006;106:820-9.

Cheng JC, Chao KS, Low D. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer. 2001;96:126-31.

Hunt MA, Zelefsky MJ, Wolden S, Chui CS, LoSasso T, Rosenzweig K, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys. 2001;49:623-32.

Xia P, Lee N, Liu YM, Poon I, Weinberg V, Shin E, et al. A study of planning dose constraints for treatment of nasopharyngeal carcinoma using a commercial inverse treatment planning system. Int J Radiat Oncol Biol Phys. 2004;59:886-96.

Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12-22.

Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol. 1998 ;16:1310-7.

Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440-50.

Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled
clinical trial. Int J Radiat Oncol Biol Phys. 2006;66:981-91.

Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312-21.

Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003;57:49-60.

Feng M, Jabbari S, Lin A, Bradford CR, Chepeha DB, Teknos TN, et al. Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer. Radiother Oncol. 2005;77:32-8.

Zhen W, Lydiatt W, Lydiatt D, Richards D, Ayyangar D, Enke A. preliminary analysis of patterns of failure in patients treated with intensity modulated radiotherapy (IMRT) for head and neck cancer: The University of Nebraska Medical Center experience.
Int J Radiat Oncol Biol Phys. 2004;60:S318-S319

Lertbutsayanukul C, Khorprasert C, Shotelersuk K, Jumpangern C, Sanghangthum T, Oonsiri S, Israngkul Na Ayuthaya I, Suriyapee S, Wadwongtham W, Supanakorn S, Kerekanjanarong V, Rojpornpradit P. Intensity-Modulated Radiation Therapy in Headand-
Neck Cancer, First Report in Thailand. J Med Assoc Thai 2006; 89:2068-76

Kwong DL, Wei WI, Cheng AC, Choy DT, Lo AT, Wu PM, et al. Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma. Cancer 2001;91:1105-13.

Langlois D, Hoffstetter S, Malissard L, Pernot M, Taghian A. Salvage irradiation of oropharynx and mobile tongue about 192 iridium brachytherapy in Centre Alexis Vautrin. Int J Radiat Oncol Biol Phys. 1998;14:849-53.

Fontanesi J, Hetzler D, Ross J. Effect of dose rate on local control and complications in the reirradiation of head and neck tumors with interstitial iridium-192. Int J Radiat Oncol Biol Phys. 1989 ;17:365-9.

Chua DT, Sham JS, Hung KN, Leung LH, Cheng PW, Kwong PW. Salvage treatment for persistent and recurrent T1-2 nasopharyngeal carcinoma by stereotactic radiosurgery. Head Neck. 2001;23:791-8.

Cmelak AJ, Cox RS, Adler JR, Fee WE Jr, Goffinet DR. Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1997;37:997-1003.

Orecchia R, Redda MG, Ragona R, Nassisi D, Jereczek-Fossa B, Zurrida S, et al. Results of hypofractionated stereotactic re-irradiation on 13 locally recurrent nasopharyngeal carcinomas. Radiother Oncol. 1999;53:23-8.

Buatti JM, Friedman WA, Bova FJ, Mendenhall WM. Linac radiosurgery for locally recurrent nasopharyngeal carcinoma: rationale and technique. Head Neck. 1995;17:14-9.

Ahn YC, Lee KC, Kim DY, Huh SJ, Yeo IH, Lim DH, et al. Fractionated stereotactic radiation therapy for extracranial head and neck tumors. Int J Radiat Oncol Biol Phys. 2000;48:501-5.

Wang CC Re-irradiation of recurrent nasopharyngeal carcinoma--treatment techniques and results. Int J Radiat Oncol Biol Phys. 1987;13:953-6.

Lee AW, Foo W, Law SC, Poon YF, Sze WM, O SK, et al. Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement. Int J Radiat Oncol Biol Phys. 1997;38:43-52.

Lu TX, Mai WY, Teh BS, Zhao C, Han F, Huang Y, et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:682-7.

Chen YJ, Kuo JV, Ramsinghani NS, Al-Ghazi MS. Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer. Med Dosim. 2002;27:171-6.